Cargando…
Combination Sodium Nitrite and Hydralazine Therapy Attenuates Heart Failure With Preserved Ejection Fraction Severity in a “2‐Hit” Murine Model
BACKGROUND: Recent studies have suggested that cardiac nitrosative stress mediated by pathological overproduction of nitric oxide (NO) via inducible NO synthase (iNOS) contributes to the pathogenesis of heart failure with preserved ejection fraction (HFpEF). Other studies have suggested that endothe...
Autores principales: | LaPenna, Kyle B., Li, Zhen, Doiron, Jake E., Sharp, Thomas E., Xia, Huijing, Moles, Karl, Koul, Kashyap, Wang, John S., Polhemus, David J., Goodchild, Traci T., Patel, Ravi B., Shah, Sanjiv J., Lefer, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111505/ https://www.ncbi.nlm.nih.gov/pubmed/36752224 http://dx.doi.org/10.1161/JAHA.122.028480 |
Ejemplares similares
-
Hydrogen Sulfide as a Potential Therapy for Heart Failure—Past, Present, and Future
por: LaPenna, Kyle B., et al.
Publicado: (2021) -
364 Beneficial Actions of SGLT2 Inhibition and H2S Therapy in Heart Failure with Preserved Ejection Fraction
por: Doiron, Jake, et al.
Publicado: (2023) -
Novel Göttingen Miniswine Model of Heart Failure With Preserved Ejection Fraction Integrating Multiple Comorbidities
por: Sharp, Thomas E., et al.
Publicado: (2021) -
Reply: Tolerating Large Preclinical Models of HFpEF But Without the Intolerance?
por: Sharp, Thomas E., et al.
Publicado: (2021) -
Combined Angiotensin Receptor–Neprilysin Inhibitors Improve Cardiac and Vascular Function Via Increased NO Bioavailability in Heart Failure
por: Trivedi, Rishi K., et al.
Publicado: (2018)